Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors  by Mackarehtschian, Katrin et al.
Immunity, Vol. 3, 147-161, July, 1995. Copyright 0 1995 by Cell Press 
Targeted Disruption of the flk2/flt3 Gene Leads to 
Deficiencies in Primitive Hematopoietic Progenitors 
Katrin Mackarehtschian,’ Jeff D. Hardin,t 
Kateri A. Moore; Sharon Boast,t 
Stephen P. Goff,t and ihor R. Lemischka’ 
“Department of Molecular Biology 
Princeton University 
Princeton, New Jersey 08544 
fDepartment of Biochemistry and Molecular Biophysics 
Columbia University 
College of Physicians and Surgeons 
New York, New York 10032 
Summary 
The f/&2 receptor tyrosine kinase has been implicated 
in hematopoietic development. Mice deficient in f/k2 
were generated. Mutants developed into heaithy adults 
with normal mature hematopoietic populations. How- 
ever, they possessed specific deficiencies in primitive 
B iymphoid progenitors. Bone marrow transplantation 
experiments revealed a further deficiency in T ceil and 
myeioid reconstitution by mutant stem ceils. Micedefi- 
cient for both c-klf and f/k2 exhibited a more severe 
phenotype characterized by large overall decreases in 
hematopoietic ceil numbers, further reductions in the 
relative frequencies of iymphoid progenitors, and a 
postnatal lethality. Taken together, the data suggest 
that f/k2 plays a role both in multipotent stem ceils and 
in iymphoid differentiation. 
introduction 
Hematopoiesis is a self-renewing process capable of con- 
tinuously producing at least eight distinct blood cell lin- 
eages (reviewed by Dexter and Spooncer, 1987; Lem- 
ischka, 1992). At the heart of this system is a population 
of hematopoietic stem cells, which are multipotent in their 
ability to differentiate and which can self-renew. Trans- 
plantation experiments have demonstrated that single 
stem cells are both necessary and sufficient for lifelong 
blood cell production (Jordan and Lemischka, 1990b; 
Smith et al., 1991). Traditionally, hematopoietic stem cells 
have been studied indirectly; that is, as activities either 
in transplantation contexts or in complex in vitro culture 
systems. Efforts in a number of laboratories have yielded 
procedures for substantial purification of these ceils, thus 
providing a means for direct mechanistic analyses of stem 
cell behavior (Visser et al., 1984; Spangrude et al., 1988; 
Ploemacher and Brons, 1989; Jordan et al., 1990). Numer- 
ous studies have implicated a panel of cytokines that act in 
vitro on purified stem cell populations (reviewed by Nicola, 
1989; Ogawa, 1993). However, relatively little information 
is available regarding the mechanisms that regulate the 
proliferation and differentiation of stem cells in a normal 
in vivo context. 
As part of an effort to identify signal transduction mole- 
cules involved in stem cell behavior, a cDNA encoding a 
novel receptor tyrosine kinase, called fk2, was identified 
in partially purified fetal liver cell populations that contain 
all primitive hematopoietic cell activities (Matthews et al., 
1991). This receptor was independently identified in testis 
cDNAs and termed fit3 (Rosnet et al., 1991). It shows sig- 
nificant sequence and structural homology to the class Ill 
receptor tyrosine kinases, which includes the colony- 
stimulating factor 1 (CSF-1) receptor (c-fms), the stem cell 
factor (SCF) receptor (c-kit), and the a and 8 platelet- 
derived growth factor receptors. Two receptors in this sub- 
family of transmembrane tyrosine kinases, namely c-fms 
and c-kit, are known to function in hematopoiesis. The 
c-fms receptor and CSF-1 play a role in the development of 
monocyte-macrophages (Stanley and Heard, 1977; Das 
and Stanley, 1982). The c-kit receptor and its iigand SCF 
are the only tyrosine kinase receptor-ligand pair presently 
known to influence the behavior of very immature hemato- 
poietic cells (Ogawa, 1993; Okada et al., 1991a; Kodama 
et al., 1992). 
The in vivo roles of c-fms and c-kit are best understood 
due to the existence of mutant mice in which genes encod- 
ing the receptors or their respective ligands are defective 
(Chabot et al., 1988; Geissler et al., 1988; Copeland et 
al., 1990; Yoshida et al., 1990). In particular, mutations 
in the c-kit receptor and its ligand are well represented by 
numerous white-spotting(W) and Steel (Si) mutant alleles, 
respectively (reviewed by Russell, 1979). The hematopoi- 
etic defects of homozygous W mice include a macrocytic 
anemia, reductions in tissue mast cells, and a decrease 
in hematopoietic stem cells (Murphy et al., 1973; Harrison 
and Astle, 1978; Harrison et al., 1979; Kitamura et al., 
1979; Russell, 1979). 
f/k2 transcripts have been detected in murine and hu- 
man cell populations enriched for hematopoietic stem and 
progenitor ceils (Matthews et al., 1991; Small et al., 1994). 
Recently, f/k2 expressing fetal liver and adult bone marrow 
cells were shown to be capable of reconstituting the hema- 
topoietic system of transplant recipients (Zeigier et al., 
1994). f/k2 is also expressed in human pre-B cell lines and 
numerous lymphoid ieukemias (Birg et al., 1992; Rosnet et 
al., 1993). Analysis of its downstream signaling pathways 
suggests that this receptor can function as a mitogenic 
signaling molecule in primitive B lymphoid cells (Dosil et 
al., 1993; Lyman et al., 1993). Two groups have reported 
the identification of the ligand for the f/k2 receptor (Lyman 
et al., 1993; Hannum et al., 1994). In combination with 
other cytokines, this molecule has potent in vitro activity 
on myeioid and lymphoid progenitors. Studies investigat- 
ing the activities of the f/k2 iigand on the most primitive 
multipotent stem cell population have not been reported. 
To analyze the role of flk2signaling in normal hematopoi- 
esis, we generated mice lacking a functional f//r2 receptor 
via homologous recombination in embryonic stem (ES) 
cells. f/k2 mutant mice developed normally and had a 
largely normal hematopoietic system. However, very prim- 
itive B lymphoid progenitor ceil populations were dimin- 
ished. Long-term transplantation experiments revealed 
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Figure 1. Generation of f//r2 Null Mutants 
(A) Strategy for disruption of the f//r2 gene. Closed boxes represent exons. The targeting vector contained approximately 14 kb of genomic f//r2 
sequence with the selectable neo’ gene inserted into exon 3. A &gene was cloned at one end of the vector to allow for enrichment of homologous 
recombination events by positive-negative selection (Mansour et al., 1988). The length of diagnostic restriction fragments and the location of 
probe A used for Southern blot analysis are shown. Enzymes are EcoRl (A), Xbal (X), and Ncol (N). Arrows represent PCR primers or the direction 
of transcription of the neo gene. 
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that the mutation impaired the developmental capacity of 
primitive progenitor cells of all hematopoietic lineages, 
having the greatest impact on progenitors of the lymphoid 
lineage. These results suggest that f/k2 and its cognate 
ligand play a role in the origin, maintenance, or expansion 
of primitive lymphoid progenitors and potentially also have 
a function in precursor cells of the myeloid lineage and 
multipotent stem/progenitor cells. 
The strong similarities in both sequence and expression 
pattern between the f/k2 and c-kit receptors suggest that 
the two molecules may play similar roles in many cells. To 
investigate this possibility, we analyzed the hematopoietic 
system of c-kit/f/k2 double-mutant mice. These studies re- 
vealed that the generation or maintenance of proper pools 
of lymphoid progenitors is dependent on these two recep- 
tors. Furthermore, combined mutations in both genes lead 
to a severe reduction in the overall size of the hematopoi- 
etic system and to postnatal lethality. These results sug- 
gest that the c-kit and the f/k2 receptors have additive 
functions in hematopoietic development. 
Results 
Generation of f/k2 Mutant Mice 
The targeting strategy was designed to yield a null muta- 
tion of the f/k2 gene. Accordingly, the gene was disrupted 
by inserting a neo cassette into exon 3 at a position corre- 
sponding to amino acid 59 of the mature protein (Figure 
1A). The targeting vector was introduced into the CCE ES 
cell line (Robertson et al., 1988). ES cells containing a 
disrupted f/k2 gene were identified by polymerase chain 
reaction (PCR) and by Southern blot analysis (data not 
shown). The targeting frequency was 1 in 5 x 1 OB electro- 
porated cells or 1 in 28 G418’FIAU’ colonies. Mice were 
generated and two were germline chimeras. Heterozy- 
gotes were intercrossed to generate mice homozygous 
for the mutant f/k2 allele (Figure 16). 
Northern blot analysis revealed an absence of f/k2 RNA 
in homozygous fetal liver and bone marrow cells (Figure 
1C). However, RNAase protection showed that the mu- 
tated gene gave rise to low amounts of RNA, encoding at 
least a portion of the f/k2 sequence (data not shown). The 
structure of the residual f/k2 transcript was analyzed by 
reverse transcriptase PCR (RT-PCR) using primers in dif- 
ferent exons flanking the neo insertion (Figure 1D). The 
sizes of the amplified products from the homozygous bone 
marrow cells were approximately 200 bp smaller than 
those from heterozygous control samples (Figure 1 D). Be- 
cause all intron-exon boundaries of the f/k2 gene have 
been mapped (K. M. and I. R. L., unpublished data), these 
data suggested a splicing-mediated deletion of the mu- 
tated exon 3. To verify this, the amplified PCR products 
were sequenced. The sequence confirmed splicing from 
exon 2 to exon 4 in the mutant f/k2 transcripts (Figure 1 D). 
This shifts the translation frame after amino acid 56, which 
results in a stop codon after 51 aa. Therefore, a functional 
f/k2 protein cannot be produced from this mRNA. 
B Lymphoid Precursor Compartments Are Reduced 
in f/&2 Mutants 
Mice carrying two mutated alleles of f/k2 were normal, 
healthy, and fertile. Genotyping of 600 mice showed that 
the targeted allele was transmitted at predicted Mendelian 
frequencies (data not shown). The analysis of a cohort of 
30 age-matched young adult flk2 homozygous, heterozy- 
gous, and wild-type mice did not reveal any differences 
in the cellularities of their hematopoietic organs. Further- 
more, peripheral blood smears and differential blood 
counts showed no morphological or quantitative abnor- 
malities (data not shown). Using a variety of cell surface 
markers (see Experimental Procedures), the absolute 
numbers and frequencies of different myeloid and lym- 
phoid cell populations were analyzed. The levels of myeloid 
and lymphoid cell populations in homozygous spleens 
were normal, as were the numbers and relative frequen- 
cies of thymocyte subpopulations (data not shown). In the 
bone marrow, no variations in monocyte, granulocyte, and 
erythrocyte levels were observed (data not shown). How- 
ever, the percentage of bone marrow B220+ cells in f/k2 
mutant mice was reduced (20.6 f 1.0 in homozygotes 
[n = 6] versus 30.8 f 1.8 in heterozygotss [n = 61, p = 
0.001) suggesting a defect in the B lymphoid population. 
The B cell lineage in adult bone marrow can be divided 
into four developmental stages (Figure 2A) (Hardy et al., 
1991). The earliest identifiable members of the B cell lin- 
eage, the pro-B cells, express 8220 and CD43. Figure 28 
shows a comparison between the B cell staining profile of 
a representative control and a f/k2 mutant mouse. Mutant 
marrow contained significantly less pro-B cells (Figure 28, 
population 1 and fractions A-C) and somewhat reduced 
numbers of pre-B cells (fraction D), whereas the percent- 
ages of more differentiated B cells were normal (subpopu- 
(8) Southern blot analysis of a litter containing wild-type (+/+), heterozygous (+/-), and homozygous (-I-) pups. Tail DNA was digested with EcoRI, 
blotted, and hybridized with probe A. Exon 3 of the f/k2 gene is contained within a 15.9 kb EcoRl fragment. Probe A hybridizes to an intron region 
upstream of exon 3 within this EcoRl fragment, but is not contained within the targeting vector. Insertion of the vector by homologous recombination 
alters the size of this fragment to 2.3 kb due to the introduction of an EcoRl site present in neo. We verified the structure of the targeted locus 
using two other restriction enzymes, Ncol and Xbal (see [A]). 
(C) Northern blot analysis of total RNA isolated from day 14 fetal liver (FL) or from adult bone marrow (BM) cells of homozygous (-I-) and 
heterozygous (+I-) mice. Each lane contains 30-40 ug of total RNA. The blots were hybridized with a f/k2 cDNA probe. Ethidium bromide staining 
of the gels and hybridization with a 3actin probe verified equal amounts of RNA in mutant and control lanes (data not shown). 
(D) RT-PCR performed on poly(A)-selected RNA isolated from bone marrow cells of heterozygous (+I-) or homozygous (-I-) mice. Primers used 
for RT-PCR and subsequent sequencing reactions are represented as arrows with primer designations on top. Primer A in exon 2 of the f/k2 gene 
was used as the upstream primer in combination with one of the downstream primers. Predicted PCR product sizes in base pairs were 295 (A 
plus E), 623 (A plus C), 334 (A plus D), and 1198 (A plus E). As a positive control, an actin fragment was amplified from each RNA preparation. 
The sizes of marker fragments (MWM) are given in base pairs. The PCR products obtained with the primer combinations A plus C and A plus D 
were sequenced. The nucleotide sequence at the splice junction (from exon 2 to exon 4) is shown. 
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Figure 2. Selective Reduction of Early B Lymphoid Progenitors in flk2 Mutant Mice 
(A) Developmental pathway of B lymphocytes in bone marrow defined by cell surface markers. 
(B) Representative analysis of the B lineage subpopulations present in normal and f/k2 mutant bone marrow. Cells isolated from a homozygous 
mutant and a wild-type control mouse were stained with monoclonal antibodies and analyzed by flow cytometry. Boxes indicate various cell 
populations: population 1, pro B cells (B220dWD43+); population 2 (C&W). Population 2 was subdivided into population D, pm-B cells 
(B220+lgMdD43-); population E, immature B cells (B220dU”CD43 IgM’) and population F, mature B cells (B220*‘rhtCD43-lgM+). The immature 
and mature B cells (subpopulations E and F) were further identified by staining for IgD expression (profiles not shown). Population 1 was subdivided 
into fraction A (BP-I-HSA-), fraction B (BP-l-HSA+), and fraction C (BP-l+HSAa). 
(C) Mean percentages of cell populations as determined by flow cytometry of mutant (open bars) and control (+I- or +/+, shaded bars) adult bone 
marrow. Values obtained for heterozygous and wild-type mice were comparable and thus pooled. All animals were age-matched outbred or inbred 
mice. The error bars represent one standard error of the mean. The number at the top of each bar indicates the number of mice analyzed. Statistical 
analysis (two-tailed t-test) gives p < 0.0001 for pro-B and p < 0.01 for pre-B cell experiments. The average total number of pro-B and pre-B cells 
per femur was 4.2 x lo5 and 8.9 x lo5 for heterozygotes (n = 12) versus 1.6 x lo5 and 5.2 x lo5 for homozygotes (n = 12) respectively. Imm 
B, immature B cells; Mat B, mature B cells. 
(D) Mean percentages of pro-8 cells in mutant (open bars) and control (+/- or +/+, shaded bars) bone marrow further subdivided into three fractions 
as defined by the expression of two additional antigens, BP-l and HSA. All mice were age-matched outbreds. Data for heterozygous and wild-type 
animals were pooled because they did not differ. Statistical analysis (two-tailed t-test) gives p < 0.095 for fraction A, p < 0.001 for fraction B, and 
p < 0.005 for fraction C. 
lations E and F). The sizes of the pro-B and pm-B cell 
compartments in f//r2 homozygotes were, on average, ap- 
proximately 49% and 74% of those in control animals, 
respectively (Figure 2C). Whereas the pro-8 cell compart- 
ment was reduced in all f/k2 knockout mice, the pre8 cell 
population ranged from reduced to normal levels among 
individual animals. This variability was not due to the ge- 
netic background, since similar results were obtained for 
outbred and 129/Sv/Ev inbred homozygotes (data com- 
bined in Figure 2C). The pro-B lymphocyte population can 
be further resolved into three distinct subpopulations (Fig- 
ure 2A) (Hardy et al., 1991). The differentiation pathway 
is believed to proceed from fraction A to B to C. This pro- 
gression is based on the decreasing stromal dependence 
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Figure 3. B Cell but Not Myeloid Progenitors Are Reduced in f//r2 Mu- 
tants 
(A) In vitro analysis of B lymphocyte and myeloid precursors present 
in adult bone marrow of homozygous mutant (open bars) and heterozy- 
gous control (shaded bars) mice. Bone marrow cells were plated in 
semisolid media in the presence of cytokine combinations: a, IL-7 
alone; b, IL-7 and SCF; c, IL-3, IL-6, SCF, and erythropoietin; d, IL-3, 
IL-6, GM-CSF, and erythropoietin. All mice were age-matched inbreds. 
Statistical analysis (two-tailed t test) gives p < 0.0001 for experiment 
a (11-7) and p < 0.05 for experiment b (IL-7 plus SCF). 
(B) Limiting-dilution analysis of stroma-dependent B cell progenitors 
in f//r2 mutant bone marrow. Bone marrow was harvested from age- 
matched homozygous (diamonds) and heterozygous (squares) mice 
and plated in limiting-dilution over 2016 stromal monolayers. The cul- 
tures were maintained in standard Whitlock-Witte conditions and B 
cell colonies were scored at two weeks. The results are from two sepa- 
rate experiments with 13 mice total, 6 heterozygous and 7 homozy- 
gous. The frequency of colony initiating progenitors at 37% negative 
wells was 11350 for heterozygous marrow (linear regression coefficient 
r = 0.996) and 113000 for homozygous marrow (r = 0.953). 
of these cells for growth and the rearrangement status of 
their immunoglobulin genes. Compared with control lit- 
termates, all three fractions in f//r2 mutants were reduced 
about O-fold (Figure 2D). 
To extend our analyses of primitive hematopoietic cells, 
in vitro colony assays for B lymphoid as well as myeloid 
progenitors were performed. Bone marrow cells from f//r2 
mutants gave rise to about 6-fold fewer 6 cell colonies 
stimulated by interleukin-7 (IL-7) and about 4-fold fewer 
colonies stimulated by IL-7 and SCF. The numbers, sizes, 
and lineage composition of myeloid (neutrophil, macro- 
phage, neutrophillmacrophage, erythroid, and mixed) col- 
onies were not significantly different between the two 
groups (Figure 3A). 
To quantitate more primitive B lymphoid progenitors, 
adult bone marrow cells were seeded in limiting dilution 
onto an established monolayer of 2016 stromal cells (De- 
ryugina et al., 1994) and maintained in B lymphoid condi- 
tions (Whitlock and Witte, 1982). In these cultures, the 
frequency of colony-initiating progenitors in homozygous 
bone marrow populations was approximately 1 O-fold 
reduced (l/350 for the heterozygous controls, but only 
l/3000 for the homozygotes) (Figure 3B). 
To address a possible function of flk2 in more primitive 
hematopoietic progenitors, a long-term culture assay was 
employed. Long-term Dexter cultures have been shown 
to maintain multipotential progenitor cells in vitro (Dexter 
et al., 1976). After 1 month, cultures initiated with either 
mutant or control cells contained similar numbers of my- 
eloid progenitors (Figure 4A). However, as seen with fresh 
bone marrow, the frequency of f/k2 mutant stroma- 
dependent B cell progenitors in these Dexter cultures was 
5-fold decreased (112600 for the heterozygous controls, 
but only l/12000 for the homozygotes) (Figure 4B). 
The colony-forming unit-spleen (CFU-S) and pre-CFU-S 
assays were used as initial measures of in vivo progenitor 
cell populations. The day 13 CFU-S assay measures my- 
eloid progenitor cells that form colonies in spleens of trans- 
plant recipients (Till and McCulloch, 1961; Magli et al., 
1962). The f/k2 mutation did not affect the frequency of 
these CFU-S progenitors. The pre-CFU-S assay measures 
a cell that is believed to be more closely related to the 
long-term repopulating stem cell (Ploemacher and Brons, 
1989). The frequency of pre-CFU-S progenitors was also 
not affected by the f/k2 mutation (Figure 4C). In addition, 
myeloid and lymphoid progenitor cells in the bone marrow 
of the primary pre-CFU-S transplant recipients were mea- 
sured. The myeloid progenitor contents were comparable, 
whereas the frequency of lymphoid precursors was signifi- 
cantly reduced (Figure 40). 
In summary, analyses of hematopoietic cell populations 
in unperturbed mutant mice, in vitro culture assays, and 
short-term transplantation experiments have shown no ap- 
parent alterations in myelopoiesis but have revealed de- 
fects in primitive B lymphoid progenitors. 
The f/k2 Mutation Affects the Long-Term In Vivo 
Repopulating Ability of Myeloid as well as 
Lymphoid Progenitors 
The only completely unambiguous assay for primitive 
stem cells is long-term transplantation. Accordingly, we 
Immunity 
152 
0 
adherent non-adherent 
C. 
12.5 1 
I 12 
CFU-S pre-CFU-S 
D. 
100 
2500 5000 7500 10000 
0 
cells/well 
1 4 
a b 
4 
I 
11 
C 
Figure 4. 6 Lymphoid but Not Myeloid Progenitors Are Reduced in Long-Term llk2 Mutant Bone Marrow Cultures 
(A) In vitro analysis of myeloid progenitors present in Dexter cultures of adult bone marrow of homozygous mutant (open bars) and heterozygous 
control (shaded bars) mice. Bone marrow was harvested from age-matched, inbred mice and was maintained for four weeks in Dexter cultures. 
The adherent and non-adherent cells were subsequently harvested and were plated in semisolid media for colony growth in the presence of IL-3 
IL-6 SCF and erythropoietin. 
(6) Limiting-dilution analysis of stroma-dependent 6 cell progenitors present in the adherent layer of Dexter cultures of flk2 mutant bone marrow. 
The frequency of colony initiating progenitors at 37% negative wells was 112600 for heterozygous marrow (r = 0.912) and 1112000 for homozygous 
marrow (r = 0.987). 
(C) Day 13 spleen colonies derived from primary (CFU-S) or secondary (pre-CFU-S) transplanted adult bone marrow of homozygous (open bars) 
or heterozygous (shaded bars) mice. 
(D) Colony assay for S cell and myeloid progenitors in f/k,? mutant transplanted bone marrow. Mean number of in vitro colonies derived from 
homozygous (open bars) or heterozygous (shaded bars) transplanted bone marrow cells are presented. Primary recipients received bone marrow 
cells from either mutant or control 129/Sv/Ev donors. The number of clonable progenitors in the bone marrow of the recipients was determined 
2 weeks later by plating in semisolid media in the presence of a, IL-7 alone; b, IL-7 and SCF; c, 11-3, IL-6, SCF, and erythropoietin. Statistical 
analysis (two-tailed t-test) gives p < 0.05 for a (IL-7) and p<O.O5 for b (IL-7 plus SW). 
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Ftgure 5. Competitive Repopulation with flk2 
Mutant Bone Marrow Cells 
(A) Peripheral blood analysis of primary recipi- 
ents 9 weeks after transplantation. The cell 
dosage is indicated and individual recipients 
are numbered. The wild-type Xbal restriction 
fragment detected with probe A (plus) is 5.7 kb 
and the mutant f//r2 allele (minus) is 4.0 kb (see 
Figure IA). 
(6) Lineage analysis of competitively repopu- 
lated mice. The reconstituted recipients were 
sacrificed 39 weeks after transplantation. Two 
representative mice are shown. Moe 17 and 
19 had each received 1 x 1 Oe mutant cells and 
1 x lb normal competitor cells. Cells isolated 
from their hematopoietic organs were sepa 
rated into various hematopoietic lineages for 
Southern analysis: (1) totat bone marrow, (2) 
bone marrow granulocytes, (3) bone marrow 
macrophages, (4) bone marrow B lymphoid 
cells, (5) total thymus, (6) total spleen, (7) 
spleen granulocytes, (5) spleen T cells, (9) 
spleen 5 cells. DNA analysis was performed 
as described above. 
(C) Peripheral blood analysis of secondary re- 
cipients 7 weeks after transplantation. Bone 
marrow cells obtained from primary recipients 
were transplanted into lethally irradiated sec- 
ondary recipients. The cell dosage for the pri- 
mary recipients is indicated. DNA analysis was 
performed as described above. 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
analyzed the ability of mutant stem cells to reconstitute 
permanent hematopoiesis in irradiated hosts. Specifically, 
a competitive repopulation experimental design was cho- 
sen (Harrison et al., 1993). In this assay, two cell popula- 
tions are transplanted into the same host to compare di- 
rectly their developmental potentials. Our experiment was 
designed to reveal deficiencies of f/k2 mutant cells when 
they are in competition with wild-type stem cells. Two dif- 
ferent doses of bone marrow from f/k2 mutant 129GvlEv 
mice (1 x 1 O6 or 4 x l@ cells/animal) were mixed with a 
constant dose of bone marrow from wild-type 129/SvEMSJ 
mice (1 x lo6 cells/animal) and engrafted into lethally 
irradiated 1296vEMSJ recipients. At two timepoints after 
engraftment, DNA samples from peripheral blood of trans- 
plant recipients were analyzed by Southern blotting. He- 
matopoietic reconstitution by mutant and wild-type stem 
cells was determined by the relative intensities of the tar- 
geted and normal f/k2 alleles. 
At 9 weeks postengraftment, this analysis revealed a 
Bfold reduction in repopulation potential of f/k2 mutant 
bone marrow cells compared with wild-type competitor 
cells (Figure 5A; Table 1). The two transplanted cell popu- 
lations contributed approximately equally when the dos- 
age of mutant cells was four times higher than that of 
competitor cells. Another blood sample, taken 26 weeks 
after transplantation, showed a similar reduction in contri- 
bution by f/k2 mutant cells (Table 1). At both timepoints 
little variation was seen between individual recipients, ex- 
cept for recipient number 11, which was reconstituted pri- 
marily by the mutant bone marrow cells (Figure 5A). 
To determine the differentiation potential of the trans- 
planted progenitor cells, the relative contribution of f//r2 
mutant cells to different hematopoietic lineages was ana- 
lyzed. Recipient mice were sacrificed 39 weeks after trans- 
plantation and representative hematopoietic lineages 
were isolated. In recipients that had received an equal 
dosage of mutant and wild-type cells, the majority of all 
hematopoietic cell types was derived from the wild-type 
marrow (Figure 58; Table 1). The contribution by f/k2 mu- 
tant cells to myeloid cell populations was reduced by 2- to 
3-fold. Mutant contribution to the bone marrow S cell popu- 
lation was reduced approximately 4-fold. Thymic T cells 
and splenic 6 cells of the recipients were derived almost 
exclusively from wild-type competitor cells. The contribu- 
tion of the f/k2 mutant cells to the T cell population in the 
spleen was not as severely reduced as in the thymus. 
Even a 4-fold increase in the injected dosage of mutant 
marrow cells did not allow these cells to compete equally 
with the wild-type marrow. In fact, the transplantation of 
larger numbers of f//r2 mutant cells resulted in an almost 
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Table 1. Competitive Repopulating Ability of f//r2 Mutant Done Marrow 
1 x 108(-/-) PIUS 1 x loa(+/+) 
Tissue Weeks Percent -I-” Decreaseb 
4 x lO”(-/-) plus 1 x loe(+/+) 
N Percent -I-’ Decreaseb N 
Blood I0 9 11 4.5 9 43 1.2 7 
Blood I0 26 11 4.5 9 34 1.5 7 
BM 39 22 2.3 0 46 1.1 6 
granulocyte 22 2.3 46 1.1 
macrophages 16 3.1 32 1.6 
B cells 14 3.6 17 2.9 
Thymus 6 8.3 2 25 
Spleen 24 2.1 33 1.5 
macrophages 20 2.5 44 1.1 
T cells 18 2.8 34 1.5 
B cells 3 16.7 3 16.7 
Blood 2 7 17 2.9 10 25 2.0 10 
The contribution of the flk2 mutant bone marrow cells to the reconstitution of hematopoietic lineages at various times after transplantation of 
irradiated recipients is tabulated. The cell dosage indicates the number of flk2 mutant (-/-) and wild-type (+/+) cells injected into each recipient 
animal. Two mice died prior to the 39 week analysis. Blood lo or 2O, blood sample taken from primary or secondary recipients, resp&vely. N, 
number of recipients that survived the experimental time period; BM, bone marrow. 
a Percent of mean contribution by -/- cells. 
b Fold reduction in mean contribution of -/- cells compared with the contribution by wild-type cells. 
complete repopulation of thymocytes by wild-type cells. 
Collectively, these resultsdemonstrated that the f/k2 muta- 
tion not only impaired the development of B cells after 
transplantation but also had an effect on the generation 
of T lymphoid and myeloid cells. 
To monitor further the proliferative potential of f/k2 mu- 
tant hematopoietic stem cells, bone marrow cells from the 
primary transplant recipients were transferred into a set 
of secondary mice. These recipients were analyzed after 
7 weeks. The relative abilities of the mutant and wild-type 
stem cells to repopulate secondary recipients were similar 
to their activities in the primary mice (compare blood lo 
and 2O in Table 1 and Figure 5). 
The Entire Hematopoletic System of W/w’ f/&2-l- 
Mutant Mice Is Diminished and Lymphoid 
Populations Are Severely Affected 
To address the possibility of a functional redundancy be- 
tween the f/k2 and c-kit receptors, mice with mutations in 
both of these genes were generated. Mating pairs con- 
sisted of a WV+ parent and a W/+ parent, one of which 
was heterozygous and the other homozygous for the f/k2 
mutation. A smaller than expected fraction of the obtained 
W/W” progeny was homozygous for the targeted f/k2 locus 
(17 W/W” flk2-l- pups versus 31 WIW’ flk2+1- pups, p < 
0.05). This distortion was not observed among WV+ or 
W/+ mice (data not shown). All live-born WNP f/k2-I- 
and WAN” f/k2+/- mice appeared to develop normally into 
white-coated adults with a slightly reduced body weight 
when compared with black littermates at 3 weeks of age 
(Figure 6A). However, even though W/WV f/k2-l- and 
W/W” f/k2+/- mice were of equivalent average size and 
weight, the overall cellularities of the bone marrow and thy- 
mus of W/W” f/k2-I- mice were approximately 5-fold and 
6-fold decreased, respectively (Figure 66). 
Flow cytometric analysis of different hematopoietic cell 
lineages revealed that the reduced cellularities in WA&P 
f/k2-I- mice encompassed both lymphoid and myeloid 
cell lineages (data not shown). In addition, a 2- to 3-fold 
further reduction in the frequencies of 6 lymphoid cells in 
the bone marrow of the W/W” f/k2-I- mice was evident 
(Table 2). The double mutants also had a slight decrease 
in the frequency of splenic B cells (Table 2). Taking into 
account the reduction in cellularity, the total number of B 
lineage cells in WAN” f/k2-I- bone marrow was reduced 
lo-fold relative to W/W” f/k2+/- mice bone marrow. 
In vitro colony assays revealed no difference in the fre- 
quencies of myeloid lineage progenitors between double- 
mutant and control marrow cells (Table 2) nor did myeloid 
cell colonies differ in type or size. However, the absolute 
number of myeloid progenitors was diminished 8-fold in 
W/W” f/k2-I- mice. We observed a 16-fold reduction in 
the frequency of in vitro colony-forming progenitors of the 
B cell lineage, which is more severe than the P-fold reduc- 
tion in precursor B cell levels observed in f/k2 single- 
mutant littermates (Table 2) (the phenotype of flk2-I- sin- 
gle-mutant mice was not as severe in this 129/Sv/Ev x 
C57BU6J outbred strain background as previously seen 
in the 1291SvlEv inbred strain background; see Figure 3A). 
Because of the reduction in bone marrow cellularity, the 
absolute number of clonogenic B lymphoid progenitor 
cells in W/W” flk2-I- mice was reduced 56-fold. B 
lymphoid progenitors were also analyzed by flow cytome- 
try. As expected, the flk2-I- single-mutant mice revealed 
a P-fold reduction in their pro-B cell compartment and no 
consistent decrease in their levels of pre-B cells (Table 
2). However, compared with f/k2 single-mutant animals, 
the pro-B and pre-B cell pools of Wm f/k2-l- mice were 
reduced by another P-fold (Table 2). It appears, therefore, 
that the diminished B lymphoid cell pools in WNP f/k2-l- 
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days after birth 
Figure 7. Viability Curve for W/W” #2-l- Pups 
Comparison between the viability of ffk2-I- (triangles) and flk2+/- 
(squares) W/W” pups. The number of living pups (y-axis) is plotted 
against the number of days after birth (x-axis). All mice were in an 
outbred strain background. 
ble 2). However, taking into account the reduction in thy- 
mus cellularity, W/w’ f/k2-I- mice had approximately 
4-fold fewer thymic CD4CD8’ and CD4+CD8- cells. Since 
the frequency of less mature thymocytes, namely the 
CD4+CD8+ and CD4-CD8- T cells was not elevated, their 
total numbers were more severely affected by the reduc- 
tion in thymus cellularity, resulting in 8- and g-fold reduc- 
tions, respectively. 
After the age of 3 weeks, W/W’ flk2-I- mice exhibited 
severely reduced viability; none have survived for longer 
than 8 weeks (Figure 7). As they approached death, some 
animalsappeared thin and weak, butoverall, W/W”flk2-I- 
mice showed no overt signsof disease. Postmortem analy- 
sis did not reveal obvious alterations. Detailed pathologi- 
cal examinations should help identify the cause of death. 
Discussion 
Mice carrying a loss-of-function mutation at the f/k2 locus 
were generated. Animals homozygous for the f/k2 muta- 
tion were viable, healthy, and fertile. The frequency of 
newborn homozygotes did not deviate from the predicted 
Mendelian frequency. The expression pattern of the f/k2 
gene had suggested a function for this receptor in hemato- 
poiesis. Accordingly, analyses of the mutant mice were 
focused on their hematopoietic system. Mature peripheral 
blood and tissue-derived hematopoietic cell populations 
in mutants were qualitatively and quantitatively identical 
to those in wild-type or heterozygous littermates. However, 
a statistically significant decrease was observed in the 
overall number of 6 lymphoid cells in bone marrow. 
The f/k2 receptor is predominantly expressed in devel- 
opmentally primitive cell populations (Matthews et al., 
1991). Accordingly, stem/progenitor cells in homozygous 
mutant mice were analyzed. A flow cytometric dissection 
of the B cell developmental pathway in bone marrow re- 
vealed depletions in three primitive pro-B cell compart- 
ments. These populations are the earliest phenotypically 
identifiable precursors of this lineage in the adult mouse. 
The absolute numbers and relative frequencies of the 
more differentiated pre-B, immature-B, and mature B cells 
were at levels largely identical to those in heterozygous 
or wild-type littermates. In vitro stromal-dependent and 
stromal-independent colony assays confirmed the reduc- 
tion in primitive B cell populations. These data suggest a 
potential role(s) for the f/k2 receptor in the maintenance, 
expansion, generation, or some combination of the three, 
of the primitive portion of the B lymphoid lineage. In long- 
term myeloid cultures, which support the survival of multi- 
potential progenitors but not that of committed B cell pre- 
cursors (Jones-Villeneuve and Phillips, 1980; Schrader 
and Schrader, 1978; Dorshkind and Phillips, 1983), the 
frequency of progenitor cells that can initiate subsequent 
stromal-dependent B lymphopoiesis was severely de- 
creased. Therefore, f/k2 may play a role in the commitment 
of a more primitive progenitor to the B cell lineage. 
The defect in B cell development in f/k2 mutant mice was 
cell intrinsic. f/k2 mutant bone marrow contained fewer 
B lymphoid precursors irrespective of whether the bone 
marrow cells were isolated directly from the mutant mice, 
recovered from transplant recipients, or maintained in cul- 
tures on wild-type stromal cell lines for extended periods 
of time. Therefore, the phenotype of f/k2 mutant mice is 
not due to insufficiencies in the microenvironment but is 
instead due to a cell intrinsic defect in hematopoietic pro- 
genitor cells. 
Analysis of three successive pro8 cell stages showed 
consistent reductions in f/k2 mutant mice; however, by the 
pre-B cell stage more normal levels were observed. One 
possible explanation of these observations is that there 
exist balancing mechanisms within the B lymphoid lineage 
that compensate for deficiencies in primitive progenitor 
cell compartments by stimulating the generation, prolifera- 
tion, or survival of more differentiated B cells. 
In vitro colony assays failed to demonstrate a deficiency 
in any population of myeloid colony-forming progenitors, 
including multipotential cells. Similarly, short-term CFU-S 
and pre-CFU-S in vivo transplantation studies revealed 
normal numbers of these progenitors in the f/k2 homozy- 
gous animals. Mutant bone marrow cells were also fully 
capable of sustaining long-term in vitro myelopoiesis in 
cultures on preestablished stromal monolayers. Taken to- 
gether, these data do not support a critical role(s) for the 
f/k2 receptor in myelopoiesis. A function for the f/k2 recep- 
tor in myelopoiesis had been previously proposed on the 
basis of antisense oligonucleotide in vitro culture experi- 
ments (Small et al., 1994). Similarly disparate results from 
antisense and gene-targeting approaches have been ob- 
served in studies of the vav gene (Wulf et al., 1993; Zhang 
et al., 1994). 
All of the above studies focused on steady-state hemato- 
poiesis in f/k2 mutants or on the ability of mutant cells to 
function in the absence of competition from wild-type cells. 
Moreover, none of these studies addressed a potential 
role for f/k2 in the behavior of the most primitive stem cell 
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population. To increase the resolution and scope of mutant 
analyses, long-term competitive repopulation studies were 
performed. The ability of mutant bone marrow cells to con- 
tribute to myeloid and lymphoid cell lineages and to total 
nucleated peripheral blood cell populations was measured 
relative to wild-type marrow. The long postreconstitution 
times of analysis insured that all mature cell populations 
in the transplant recipients were derived from primitive 
stem cells rather than from more committed progenitors. 
The competitive reconstitution experiment magnified 
and extended the f/k2 mutant phenotype. In contrast with 
the experiments discussed above, this study revealed an 
impaired ability of mutant stem cells to contribute to both 
myeloid and lymphoid cell populations. However, mutant 
stem cell contribution to B and T cell lineages was more 
severely affected than contribution to myeloid cell popula- 
tions. The long-term nature of these studies suggests a 
possible role for f/k2 in multipotent stem cells or their imme- 
diate clonal progeny. 
Of particular significance is the marked deficiency in 
repopulation of the T cell lineage by mutant cells. This 
result complements our previous finding that f/k2 is ex- 
pressed in a primitive thymocyte subset defined as 
CD4-CD8-Thy-1’01L-2R- (Matthews et al., 1991). A statisti- 
callysignificant, though subtle, decrease in this thymocyte 
population in f/k2 mutant mice at postnatal days O-2 was 
also observed (data not shown). The levels of all other 
thymocyte subsets were normal, as were the levels of this 
very primitive subset in mice of different pre- or postnatal 
stages. It is possible that a more elaborate analysis of 
CD4CD8- cell subsets will reveal additional immature pro- 
genitor decreases at other developmental stages. Taken 
together, our results clearly demonstrate a role for f/k2 in 
T cell development, possibly analogous to its role in the 
B cell lineage. 
The f/k2 receptor was recently shown to be expressed on 
a subset of long-term reconstituting stem cells. Moreover, 
f/k2-expressing stem cells appear to be predominantly in 
active cell cycle (Zeigler et al., 1994). Within the population 
of stem cells, there is a direct correlation between cell 
cycle activity and commitment to differentiation (Lem- 
ischka, 1992). Therefore, the f/k2 receptor could function 
within a subpopulation of stem cells poised for active he- 
matopoiesis. As such, it could function in commitment/ 
differentiation processes rather than in self-renewal events. 
Accordingly, the mutant stem cells should display no de- 
fect in their ability to self-renew. The observation, that the 
hematopoietic activity of transplanted mutant stem cells 
is stable over long time intervals, is consistent with this. 
A more stringent measure of self-renewal is the ability of 
stem cells to function upon serial retransplantation. Re- 
transplantation of marrow from the reconstituted animals 
did not reveal a further quantitative impairment in the abil- 
ity of mutant stem cells to contribute to mature blood cells. 
This is a strong indication that the f/k2 mutation does not 
impair the self-renewal process. Importantly, the observed 
similarities for mutant stem cell activity in primary and sec- 
ondary recipient animals also suggest that the f/k2 re- 
ceptor does not play a major role in stem cell engrafting 
parameters such as homing and seeding of bone marrow 
microenvironments. 
Although our studies suggest the importance of f/k2 in 
lymphoid development and in multipotential stem cell dif- 
ferentiation pathways, the viability of the mutants and the 
subtle nature of the phenotype suggest the existence of 
at least one compensatory pathway. Owing to similarities 
in structure and expression pattern, an obvious candidate 
for such a role is the c-kit receptor. Both receptors are 
expressed in multipotent hematopoietic progenitor cells 
capableof long-term reconstitution of irradiated mice (Mat- 
thews et al., 1991; Ogawa et al., 1991; Okada et al., 
1992). The c-kit receptor and its ligand are also thought 
to be involved in lymphopoiesis (Rolink et al., 1991; Billips 
et al., 1992; Palacios and Samaridis, 1992). Accordingly, 
the consequences of combining the f/k2 mutation with mu- 
tations at the c-kit locus were investigated. The W and the 
WV alleles of c-kit were chosen, because this combination 
(W/W”), although severely anemic, is viable (Russell, 
1979). Surprisingly, W/W” animals homozygous for the f/k2 
mutation were obtained, albeit at lower than expected fre- 
quency. This indicates that hematopoietic development 
can occur in the absence of the f/k2 receptor and severely 
reduced c-kit receptor activity. 
In contrast with c-kit or f/k2 single-mutant animals, mice 
homozygous for both c-kit and f/k2 mutations had severely 
reduced myeloid and lymphoid cellularities in their primary 
hematopoietic organs. Thus, both receptors have func- 
tions that together provide for normal overall levels of 
blood cells. f/k2 may therefore function together with c-kit 
in the progenitor cells of all hematopoietic cell lineages. 
Alternatively, the two receptors could function separately 
at distinct stages of hematopoiesis and their coordinated 
activities may insure the production of normal numbers 
of hematopoietic cells. 
The two receptors also appear to function together in 
lymphoid development. The absolute numbers of bone 
marrow B cells and thymic T cells were decreased in the 
double mutants. Furthermore, W/W” animals homozygous 
for the f/k2 mutation possessed a greater reduction in pro- 
genitor B cell frequency than f/k2 or c-kit single-mutant 
animals. In addition, the relative frequencies of T lymphoid 
cells were altered in favor of mature T lymphocytes. Since 
neither c-kit, nor flk2, are expressed in mature T cells or 
in their immediate CD4+CD8+ precursors (Matthews et al., 
1991; Palacios and Nishikawa, 1992) this increase in fre- 
quency may reflect compensatory mechanisms in this lin- 
eage, which function to correct deficiencies in primitive 
cell pools. Alternatively, it is possible that the lack of func- 
tional f/k2 and c-kit receptors causes an acceleration of 
differentiation in the T cell lineage, leading to a relative 
increase in the percentages of mature cells. 
In summary, it appears that signaling through two struc- 
turally related molecules, the c-kit and f/k2 receptors, in- 
sures the proper production or expansion of hematopoietic 
progenitors, leading ultimately to the generation of ade- 
quate populations of mature hematopoietic cells. Because 
of the striking reduction in the viability of double-mutant 
mice, it seems likely that their combined functions in the 
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hematopoietic system are vital to the survival of the or- 
ganism. 
Experimental Procedures 
f/k2 Homologous Recombination Constructs 
To construct the targeting vectors, four fragments were ligated: the 
upstream and downstream f/k2 gene sequences, the PGK-1 -neo gene, 
and the MCl-t/r gene. From cosmid clone 16-1 (isolated from a 129 
isogenic mouse genomic library [gift from Dr. L. Silver, Princeton Uni- 
versity]), which contains the 5’half of the f/k2 gene, a 2.6 kilobase (kb) 
EcoRI-BamHI fragment was isolated and subcloned into the pSport1 
vector (GIBCO BRL). The insert was sequenced from the BamHl side 
to verify that this restriction site was located in exon 3 of the f/k2 gene. 
A 1 .O kb fragment reaching from this BamHl site to a Pstl site located 
further upstream was isolated, Hindlll linkers were added to the Pstl 
site, and the BamHl site was blunted. This fragment was then cloned 
into the PGK-1-neo plasmid that had been linearized with EcoRV and 
Hindlll to yield subclone Ill-l. A 13.2 kb BamHl fragment containing 
f/k2 exons 4-9 as well as part of exon 3 was isolated from cosmid 
clone 16-1 and modified with Notl linkers. The fragment was ligated 
in the correct orientation into subclone Ill-1 cut with Notl to derive 
subclone 111-2. Finally, a 1.66 kb Clal-Sal1 fragment containing the 
MCi-t/r gene was isolated from the plClSR-MCI-TK plasmid and 
ligated with subclone Ill-2 cut with the same enzymes to yield the 
f/k2 targeting construct Ill. The vector was linearized with Sal1 before 
introduction into ES cells. The pPGK-neo bpA and plClSR-MCI-TK 
plasmids were a gift from Dr. E. Robertson (Harvard University). 
Transfectlon and Selection of ES Cells 
CCE ES cells (Robertson et al., 1966) were grown as previously de- 
scribed (Robertson, 1967). Confluent plates of ES cells were harvested 
and electroporated with 10 vg/ml of DNA using a Gene Pulser (Bio- 
Rad). The cells were selected in 6416 (0.6 mg/ml, GIBCO BRL) and 
(1-[Z-deoxy, 2-fluoro-6-o-arabinofuranosil-l-5iodouracil) FIAU, 0.2 pM 
final concentration (Oclassen Pharmaceutical, Incorporated). Colo- 
nies were picked and expanded. 
PCR Screening and Southern Blot Analysis of 
Recombinant Clones 
DNA was extracted from ES cells as previously described (Laird et 
al., 1991). PCR analysis was performed with primers derived from the 
f/k2 genomic sequence upstream of the Pstl site preceding exon 3 
(5’-ACAGTGCTCAGTACCTATAG-3’) and from the neo gene (5’- 
TAAAGCGCATGCTCCAGACT-3’). The size of the fk2heo PCR prod- 
uct diagnostic for a homologous recombination event is 1 .O kb. DNA 
from PCR-positive ES clones was digested with Xbal, EcoRI, or Ncol, 
Southern blotted, and hybridized with a 150 bp PCR-amplified frag 
ment (PCR primer sequences were 5”CAGATGTGCCATGTGGTA- 
3’ and 5”CTATAGGTACTGAGCACTGT-3’) that contains f/k2 intron 
sequence (probe A). Hybridization conditions were as previously de- 
scribed (Jordan and Lemischka, 1990). Probes were labeled by the 
hexamer extension method (Feinberg and Vogelstein, 1963). 
Generation of Chlmeric Mice 
Chimeras were generated as described (Bradley, 1967). Approxi- 
mately lo-15 ES cells were injected into C57BU6J blastocysts at 3 
days postcoitum. The embryos were transplanted surgically to the uteri 
of pseudopregnant C57BU6.l x DBA Fl recipients 2.5 days postcoi- 
turn. Pups were scored for chimerism on the basis of agouti coat color. 
Chimeric males were bred to female C57BU6J or 129/Sv/Ev mice, 
the strain from which the CCE line was derived (Robertson et al., 1966). 
Germline transmission was scored by the presence of agouti coat color 
in the Fl animals. 129/Sv/Ev mice carrying the mutation were bred 
back to 129/Sv/Ev mice to generate inbred mutant mice. 
Animals 
Animals were housed under nonsterile conditions in a conventional 
animal facility. They were provided with standard lab chow and water 
ad libidum. C57BL/6J, 129/SvJ, and 129/SvEMSJ mice were obtained 
from the Jackson Laboratory (Bar Harbor, Maine). The C57BU6J x 
DBA Fl blastocyst recipients as well as the vasectomized males of the 
same genetic background were obtained from Charles River. Breeding 
pairs of W/+ and WV/+ mice in the C57BU6.l background were the 
gift of Dr. P. Besmer (Sloan Kettering Institute, New York). Their 
W/W”, +/+, W/+, and W”/+ offspring were identified by their coat colors. 
All mice were genotyped for the f/k2 mutation by Southern blotting. 
RNA Analysis 
Total RNA from day 14 fetal liver or adult bone marrow was purified by 
the guanidinium-isothiocyanate protocol followed by cesium chloride 
centrifugation (Ausubel et al., 1967). For Northern analysis, 30-40 ug 
of RNA was blotted and hybridized with a =P-labeled f//r2 cDNA probe 
(a 3.5 kb fragment covering the entire coding region). Final washes 
were at 65°C in 0.1 x SSC, 0.1% SDS. For PCR analysis of RNA, 
reverse transcription was performed with the Superscript II kit (GIBCO 
BRL) on poly(A)-selected RNA isolated from adult bone marrow cells. 
The resulting cDNA was amplified by PCR using the following f//Q- 
specific primers: primerA, bp96(5’-TCTTGAGACCGlTACAAACCd’); 
primer B, bp 391 (5’AATCAAAGTGCGGCTGGC31; primer C, bp 719 
(5’-ATGTCTGTTCCGAACAACTC-3’); primer D, bp 960 (5’-AAGGCCA- 
AGAGAATCCGAAT-3); primer E, bp 1292 (5”GCATAGAATATGTAC- 
TCTCC-3’). PCR conditions were optimized using the Opti-Prime PCR 
kit (Stratagene). For subsequent sequencing, single-stranded tem- 
plate was generated from the PCR products by asymmetric PCR as 
described (McCabe, 1990). The Sequenase kit (US Biochemical) was 
used for sequence analysis. 
Flow Cytometry Analysis 
Single cell suspensions were prepared from individual tissues, includ- 
ing bone marrow, spleen, and thymus, by standard procedures (Parks 
et al., 1966). The antibodies RA3-6B2 (rat anti-mouse CD45R [B220], 
allophycocyanin-conjugated), R6-60.2 (rat anti-mouse immunoglobu- 
lin M [IgM], biotin-conjugated), rat anti-mouse Mac-l (R-phycoerythrin- 
conjugated), rat anti-mouse Gr-1 (fluorescein isothiocyanate-conju- 
gated), and streptavidin (Texas red-, fluorescein isothiocyanate-, or 
R-phycoerythrin-conjugated) were purchased from PharMingen. Rat 
anti-mouseTerll9 wasagiftfrom Dr. T. Kina(Kyoto University, Japan) 
and monoclonal antibodies Ml/69 (rat anti-mouse HSA), 6C3 (rat anti- 
mouse 6C3/BP-l), 57 (rat anti-mouse leucosialin (CD43), and rat anti- 
mouse IgD were a gift from Dr. A. Stall (Columbia University). All 
antibodies were titrated on tissues (normal spleen, thymus, and bone 
marrow) with distinct positive and negative subpopulations and used 
at saturating concentrations and were compared with isotype controls. 
Approximately 1 x 1 OB cells were used for most stainings. Generally, 
the cells were first blocked with normal rat serum. They were then 
incubated on ice with the first antibody, washed three times in PBS 
plus 3% fetal calf serum (FCS) and resuspended in PBS plus 3% FCS. 
The next antibody or a secondary antibody was added for another 
incubation on ice followed by another three washes in PBS plus 3% 
FCS before FACS analysis. Background controls were treated identi- 
cally except that primary antibodies were omitted. Cells were initially 
gated by size and by scatter to identify live cells. In some expertments, 
cell viability was also monitored by propidium iodide staining. Data 
from l-5 x 10’ gated cells was collected. The statistical evaluation 
of the data was done with the StatView 4.02 software package (Abacus 
Concepts, Incorporated). 
In Vitro CFU Assays 
CFU assays were performed as previously described (Okada et al., 
1992). For each sample, 2 x 10’ cells were plated in triplicate in 1 
ml cultures. The culture mixture consisted of 1.2% methylcellulose 
(Fischer-Scientific) in aMEM containing 30% FCS, 0.1 mmolll 6-mer- 
captoethanol, and 1% deionized bovine serum albumin and was sup 
plemented with growth factors (5 U/ml recombinant human [rh] erythro- 
poietin [Epo] [Rand D Systems, Incorporated, Minneapolis, Minnesota], 
2 @ml recombinant mouse [rm] IL-7 [UBI, Lake Placid, New York], 
100 rig/ml rh IL-6 [UBI], 10 @ml rm IL-3 [USI], IO nglml rm SCF 
[Genzyme, Cambridge, Massachusetts]). The cultures were main- 
tained at 5% COz and 37OC. The CFU-B (rm IL-7) cultures were 
counted using an inverted microscope 5 days after plating, whereas 
the CFU-C (rh IL-6, rm IL-3, rh EPO, rm SCF) and CFU-B (rm IL-7, rm 
SCF) plates were scored after 7 days. Experiments involving young 
W/W’ mice were done as described above except that 4 x 10’ bone 
marrow cells were plated per dish and SCF was omitted. 
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Stromaf Cultures 
Stromal cocultures were established with two different day 14 fetal liver 
stromal cell lines. The 2016 stromal line has been shown to support B 
cell progenitors in Whitlock-Witte conditions (Deryugina et al., 1994; 
R. Wager et al., unpublished data). The AFT024 stromal line has been 
shown to efficiently support high levels of myeloid-erythroid progeni- 
tors, late-appearing cobblestone area cells, and long-term in vivo re- 
populating stem cells in Dexter conditions (R. Wager et al., unpub- 
lished data). The Dexter-myefoid culture media was 10% FCS, 10% 
horse serum, 50 uM Q-mercaptoethanol, 0.1 uM hydrocortisone in 
DMEM (modified from Dexter et al., 1976). Cultures were maintained 
at 33OC in 5% CO*, 100% humidity. Whitlock-Witte culture media 
was 5% FCS, 2 mM glutamine, 1 mM sodium pyruvate, 100 U/ml 
penicillin, 50 us/ml streptomycin in RPM1 1640 (Whitlock and Witte, 
1962). Cultures were maintained at 37’X in 5% C02, 100% humidity, 
Stromaf cells were plated on gelatin coated dishes and irradiated (2000 
rads) when subconfluent. Dexter cocuflures were initiated with 106 
bone marrow cells/ml and maintained for 4 weeks with weekly half- 
volumemediachanges. Limiting-dilution Whitlock-Wittecultureswere 
performed in 96-well trays, 24 wells per cell dilution. Media was 
changed weekly and colonies were counted at 2 weeks. The limiting- 
dilution data was evaluated by linear regression analysis. 
CFU-S and Pre-CFU-S Assays 
Assays were performed as previously described (Till and McCulloch, 
1961; Pfoemacher and Brons, 1969; Magfi et al., 1962). The recipients 
were irradiated with 950 rads (137 Cs source) administered in two 
equal doses 3 hr apart. This dose is sufficient to eliminate endogenous 
spleen colony formation completely. For day 13 CFU-S, they were 
injected intravenously with 1 x 105 bone marrow cells. All recipients 
were maintained in microisolator cages on sterilized food and acidified 
sterile water containing I@ U/liter pofymyxin B sulfate and .I g/liter 
neomycin sulfate. The recipients were killed after 13 days, their 
spleens were fixed in Teleyesniczky’s solution (70% ethanol:acetic 
acid:formafin, 20:1:1), and macroscopic colonies were counted. For 
the pre-CFU-S assay, four primary 129lSvEMSJ recipients for each 
group were transplanted with 1 x IOn femoral marrow cells isolated 
from either three mutant or control donor mice. Bone marrow cells 
obtained from these primary recipients 14 days later were pooled and 
then injected into secondary 129/SvJ mice, 1 x 105 cells per recipient. 
Spleen colonies were enumerated at 13 days. 
Comfx4ftfve Repopulation 
129lSvEMSJ recipient mice were irradiated and maintained as de- 
scribed above. Bone marrow cell suspensions were prepared from 
femurs and tibias of three f/k2 homozygous 129/Sv/Ev donor mice or 
three wild-type 129lSvEMSJ competitor mice. The cell suspensions 
were then mixed at I:1 and 4:1 (mutant:wild-type) ratios. Doses of 2 
x IO and 5 x 108 cells were then injected intravenously. Repopulation 
of the hematopoietic system after transplantation was determined by 
Southern blotting. Blood was obtained from the retro-orbital sinus and 
genomic DNA was extracted as described (Jordan and Lemischka, 
1990). After 9 months the primary recipients were sacrificed, their 
hematopoietic organs were harvested, and cell lineages were fraction- 
ated as described (Jordan and Lemischka, 1990). The purity of the 
myeloid and lymphoid fractions was 80%-90% as assessed by stain- 
ing for lineage-specific antigens (Gr-1, Thy-l .2,8220, Mac-l) and flow 
cytometry. Monocyte-macrophages were grown in L cell-conditioned 
medium for 6-10 days as described (Jordan and Lemischka, 1990). 
Secondary recipients were injected with bone marrow cells pooled 
from the primary recipients (2 x 10Bcells/animaf). DNA was extracted 
from all cell fractions. The intensity of individual bands on filters repre- 
senting wild-type or targeted f/k2 alleles was measured using a Phos- 
pholmager (Molecular Dynamics) and quantitated using the Im- 
ageQuant software packet. The efficiency of transfer and hybridization 
of the two bands was controlled for by inclusion of DNA samples from 
heterozygous f/k2 mice on each blot. 
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